Integrum Introduces Global Marketing Strategy at AOPA Assembly
Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), a leading provider of the OPRA™ Implant System, has rolled out an innovative global marketing strategy during the American Orthotic & Prosthetic Association's (AOPA) National Assembly. This pivotal initiative emphasizes BondedMatrix™, a term that encapsulates the OPRA™ Implant System's unique ability to unify soft tissue and bone, thereby enhancing patient outcomes globally.
Understanding BondedMatrix™
BondedMatrix™ symbolizes the biologically integrated barrier formed at the skin-bone penetration site following healing. This innovative design is a hallmark of the OPRA implant process, achieved through a proprietary surgical technique tailored for optimal integration. With the introduction of BondedMatrix™, Integrum aims to clarify the numerous advantages of the OPRA system for a worldwide audience.
The Vision Behind BondedMatrix™
"This effort is about fostering a common language that makes the benefits of OPRA™ more accessible to clinicians, prosthetists, and the patients they serve,” stated Jeffrey Zanni, President of Integrum Inc. “Introducing BondedMatrix™ empowers our partners to effectively communicate the reasons OPRA™ is the foremost solution available for bone-anchored prosthetics."
Transforming Patient Experiences
Dr. Rickard Brånemark, who invented the OPRA Implant System and founded Integrum, has been advancing this surgical method in collaboration with international partners since 1990. Over 1,000 OPRA implants have been successfully placed, enabling countless amputees to reclaim their mobility and independence.
Expert Insights on BondedMatrix™
According to Dr. Jason Souza, a pioneering figure in bone-anchored prosthetics and Director of the Advanced Amputation Program at Ohio State University, "BondedMatrix™ is essentially a new terminology that encapsulates a critical element behind Integrum's long-standing success in osseointegration. Patients desire a reliable and dry skin-implant interface— a BondedMatrix. OPRA is unique in delivering this consistently, and I'm thrilled that patients now have a way to request it explicitly."
Engagement at AOPA 2025
Integrum is actively presenting this strategy at booth #931 throughout AOPA 2025, featuring interactive discussions and educational materials. The company will also host a dinner featuring Dr. Jason Souza, emphasizing patient outcomes and sharing valuable clinical experiences related to OPRA and BondedMatrix™.
Contact Integrum for More Information
For more insights about BondedMatrix™ and the OPRA™ Implant System, interested parties are encouraged to reach out to Integrum directly.
Contact Details
For further information, please contact:
Jeffrey Zanni, President US
Email: Contact Us
Phone: +1 617-839-1600
Jörgen Svanström, CFO
Phone: +46 (0) 7073 496 60
Email: Contact Us
Frequently Asked Questions
What is BondedMatrix™?
BondedMatrix™ is a term used to describe the biologically integrated barrier that forms at the skin-bone interface following the healing process after the implantation of the OPRA™ system.
How does the OPRA™ Implant System work?
The OPRA™ Implant System integrates bone and soft tissue through a patented surgical technique, offering significant advantages for amputees looking to regain mobility.
Who developed the OPRA Implant System?
The OPRA Implant System was developed by Dr. Rickard Brånemark, who has been perfecting this technique since 1990 with numerous global partners.
Where can I learn more about Integrum?
For comprehensive information regarding Integrum and its products like BondedMatrix™, visit their official website or contact them directly.
Why is BondedMatrix™ important for patients?
BondedMatrix™ represents the reliability of the skin-implant interface, ensuring better patient outcomes and satisfaction through improved integration of the device with the body.
